₹103.5
▼ -3.9 -3.63%
10 Sept 2026
NSE Listed · Chemicals
Neochem Bio Solutions Ltd. (NEOCHEM)
Volume: 2,08,800Avg Vol 1W: 1,02,000Avg Vol 1M: 34,09152W Range:₹63₹121
Key Ratios
Checked just nowMarket Cap—
Current Price₹103.5
Previous Close₹107.4
High / Low (52w)₹121 / ₹63
Volume2,08,800
Avg Vol (1W)1,02,000
Avg Vol (1M)34,091
Stock P/E0
Book Value₹41.89
Dividend Yield0%
ROE15.25%
ROA0%
Revenue (TTM)—
Revenue Growth—
Profit Margin0%
Total Debt—
Shares Outstanding—
Face Value—
EPS (TTM)₹0
P/B2.47
Debt / Equity2.17
50 DMA₹93.89
200 DMA—
Day change-3.63%
Price Chart
₹103.5▼ 7.59% · 1Y
2025-12-092026-09-10
20-day avg volume: 36K shares
Pros
- Healthy return on equity of 15.3%.
- Company is almost debt-free.
- Revenue grew 39% YoY.
- Net profit is growing year over year.
Profit & Loss (Annual)
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Revenue | ₹49 Cr | ₹49 Cr | ₹62 Cr | ₹86 Cr |
| EBITDA | ₹3 Cr | ₹4 Cr | ₹6 Cr | ₹14 Cr |
| Net Profit | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹8 Cr |
| EPS | 3.24 | 2.1 | 1.9 | 6.64 |
Balance Sheet
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Total Assets | ₹46 Cr | ₹51 Cr | ₹64 Cr | ₹79 Cr |
| Total Liabilities | ₹42 Cr | ₹42 Cr | ₹52 Cr | ₹59 Cr |
| Equity | ₹4 Cr | ₹8 Cr | ₹12 Cr | ₹20 Cr |
| Total Debt | ₹15 Cr | ₹12 Cr | — | — |
Cash Flow
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Operating | ₹-1 Cr | ₹-1 Cr | ₹2 Cr | ₹3 Cr |
| Investing | ₹-3 Cr | ₹-3 Cr | ₹-8 Cr | ₹-2 Cr |
| Financing | ₹4 Cr | ₹4 Cr | ₹6 Cr | ₹-1 Cr |
| Free Cash Flow | ₹-1 Cr | ₹-1 Cr | ₹2 Cr | ₹3 Cr |
Shareholding
Promoter 66.72% Institutions 16% Public 17.28%
Efficiency & Working Capital
ROCE27.2%
Interest Coverage3.9
Dividend Payout—
Debtor Days110 d
Inventory Days103 d
Payable Days71 d
Cash Conversion Cycle142 d
Working Capital Days213 d
Shareholding Details
As of 2026-03-31
Promoter66.7%
FII0.2%
DII15.8%
Institutions16%
Public17.3%
Promoter Pledge0%
No. of Shareholders406
Shareholding Pattern
Quarterly — figures in %. Latest 6 quarters.
| Period | Aug 2025 | Aug 2025 | Nov 2025 | Nov 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 91.1% | 91.1% | 91.1% | 91.1% | 66.7% | 66.7% |
| FIIs | 0% | 0% | 0% | 0% | 2% | 0.2% |
| DIIs | 8.9% | 0% | 8.9% | 0% | 13.2% | 15.8% |
| Public | 0% | 8.9% | 0% | 8.9% | 18.1% | 17.3% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 14 | 14 | 14 | 14 | 861 | 406 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202603 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Swapnil Rameshbhai Makati | Shareholding of Promoter and Promoter Group | 54.6% | 93,46,475 |
| Hemangini Swapnil Dathia | Shareholding of Promoter and Promoter Group | 6.3% | 10,80,625 |
| Meenaben Rameshbhai Dathia | Shareholding of Promoter and Promoter Group | 5.8% | 9,95,925 |
| Sanshi Fund-i | Shareholding of Promoter and Promoter Group | 3% | 5,11,200 |
| Mavira Growth Opportunities Fund | Shareholding of Promoter and Promoter Group | 2.9% | 4,99,200 |
| Finavenue Capital Trust - Finavenue Growth Fund | Shareholding of Promoter and Promoter Group | 2.7% | 4,54,800 |
| Sheetal Sagar Builders & Developers Private Limited | Public Shareholding | 2.2% | 3,78,000 |
| Invicta Continuum Fund I | Shareholding of Promoter and Promoter Group | 1.9% | 3,30,221 |
| Venturex Fund I | Shareholding of Promoter and Promoter Group | 1.8% | 3,08,729 |
| Dinesh Chopra | Public Shareholding | 1.5% | 2,62,500 |
| Aarth Aif Growth Fund | Shareholding of Promoter and Promoter Group | 1.4% | 2,34,000 |
| Rikhav Securities Limited | Public Shareholding | 1.3% | 2,24,400 |
| Swapnil Rameshbhai Dathia (huf) . | Shareholding of Promoter and Promoter Group | 0% | 175 |
| Dhairya Swapnil Dathia | Shareholding of Promoter and Promoter Group | 0% | 175 |
| Kyra Swapnil Dathia | Shareholding of Promoter and Promoter Group | 0% | 175 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Dinesh Chopra | Chairman & Non Executive Dir. | 2025 |
| Swapnil Rameshbhai Makati | ED / MD / Promoter | 2025 |
| Hemangini Swapnil Dathia | WTD & Executive Director | 2025 |
| Falgunbhai Prajapati | Independent Non Exe. Director | 2025 |
| SHAH JAYESH SHAIL | Independent Non Exe. Director | 2025 |
| GUHA RAJASEKARAN | Non Executive Director | 2025 |
| Shradha Agarwal | Company Sec. & Compli. Officer | 2025 |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| Local | ₹107 Cr | 96.4% |
| Export | ₹4 Cr | 3.6% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2026 | ₹10 | 25 | 17 | 17 |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 0 | 0 | 0 | 7 | 39 | 46 |
| 2025 | 0 | 0 | 0 | 5 | 36 | 42 |
| 2025 | 0 | 0 | 0 | 1 | 1 | 2 |
Company Information
🌐 www.neochem.in ↗
📍 303 W1 Off.Iscon Ambli Road, Ambli, Ahmedabad, Gujarat, 380058
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Neelamalai Agro Industries Ltd.North Eastern Carrying Corporation Ltd.Nectar Lifesciences Ltd.Neelam Linens and Garments (India) Ltd.Nelcast LimitedNELCO Ltd.Neogen Chemicals LimitedNephro Care India LimitedNephrocare Health Serv LimitedNeptune Petrochemicals LimitedNesco Ltd.Nestle India LimitedAll “N” stocks →
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search